Literature DB >> 11002219

Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma.

T Seki1, T Tamai, T Nakagawa, M Imamura, A Nishimura, N Yamashiki, K Ikeda, K Inoue.   

Abstract

BACKGROUND: A small number of microwave electrode insertions and microwave irradiations were used to obtain complete tumor necrosis in hepatocellular carcinomas (HCC) measuring > 2.0 cm but </= 3.0 cm in greatest dimension. The efficacy of combining transcatheter arterial chemoembolization (TACE) with subsequent percutaneous microwave coagulation therapy (PMCT) was assessed in this study.
METHODS: Eighteen patients with cirrhosis and HCCs measuring > 2.0 cm but </= 3.0 cm in greatest dimension underwent TACE followed within 1-2 days by ultrasonographically guided PMCT.
RESULTS: On dynamic computed tomography, 17 of the 18 patients showed complete necrosis of their tumor lesions and the treated tumor margins (>/= 5 mm). Necroses of tumors and noncancerous margins surrounding the tumors were obtained using 4 microwave irradiations (1 session) in 14 patients, 5 microwave irradiations (2 sessions) in 2 patients, and 6 microwave irradiations (2 sessions) in 1 patient. The follow-up period was short (12-31 mos), and all patients remained alive. No local recurrences in the treated areas were detected. No fatal complications were observed. Pleural effusion was observed in 1 patient only.
CONCLUSIONS: This combined therapy of PMCT applied within 1-2 days of TACE effectively treated HCCs measuring > 2.0 cm but </= 3.0 cm in greatest dimension. A small number of microwave electrode insertions and microwave irradiations were used. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11002219

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 2.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

3.  Simultaneous injection of autologous mononuclear cells with TACE in HCC patients; preliminary study.

Authors:  Alaa Ismail; Ahmed AlDorry; Mohammed Shaker; Reda Elwekeel; Khaled Mokbel; Doaa Zakaria; Anas Meshaal; Firas Zahr Eldeen; Abdulhafez Selim
Journal:  J Gastrointest Cancer       Date:  2011-03

4.  MR-arterioportography: a new technical approach for detection of liver lesions.

Authors:  Janine Rennert; Ernst-Michael Jung; Andreas G Schreyer; Patrick Hoffstetter; Peter Heiss; Stefan Feuerbach; Niels Zorger
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

Review 5.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

Review 6.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

Review 7.  Technical and practical considerations for device selection in locoregional ablative therapy.

Authors:  Sean P Zivin; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

8.  Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

Authors:  Akitoshi Douhara; Tadashi Namisaki; Kei Moriya; Mitsuteru Kitade; Kosuke Kaji; Hideto Kawaratani; Kosuke Takeda; Yasushi Okura; Hiroaki Takaya; Ryuichi Noguchi; Norihisa Nishimura; Kenichiro Seki; Shinya Sato; Yasuhiko Sawada; Junichi Yamao; Akira Mitoro; Masakazu Uejima; Tsuyoshi Mashitani; Naotaka Shimozato; Soichiro Saikawa; Keisuke Nakanishi; Masanori Furukawa; Takuya Kubo; Hitoshi Yoshiji
Journal:  Oncol Lett       Date:  2017-06-28       Impact factor: 2.967

Review 9.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.

Authors:  Thomas Josef Vogl; Jun Qian; Andreas Tran; Elsie Oppermann; Nagy N Naguib; Huedayi Korkusuz; Nour Eldin A Nour Eldin; Wolf Otto Bechstein
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.